Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

No Comments

Zenapax enters clinical trials for uveitis

Nov. 1, 1996

No Comments

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

No Comments

PDL signs agreement with Roche for humanized antibody

Nov. 1, 1996

No Comments

Collagenase inhibitor from Roche for arthritic conditions

Nov. 1, 1996

No Comments

Antiarthritic agents reported by Kaken

Nov. 1, 1996

No Comments

ADIR investigates COX-2 inhibitors

Nov. 1, 1996

No Comments

Key lupus patent issued to Genelabs

Oct. 25, 1996

No Comments

AM-425 available for licensing

Oct. 25, 1996

No Comments

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Musculoskeletal
RSS

Antiarthritic agents with good safety reported by Toyama

Zenapax enters clinical trials for uveitis

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

PDL signs agreement with Roche for humanized antibody

Collagenase inhibitor from Roche for arthritic conditions

Antiarthritic agents reported by Kaken

ADIR investigates COX-2 inhibitors

Key lupus patent issued to Genelabs

AM-425 available for licensing

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Today's news in brief

Today's news in brief

Second insulin receptor offers new therapeutic avenues

KITE-753, a rapid manufactured CAR T therapy with superior antitumor efficacy and enhanced expansion in vivo

Boryung invests $10M in Intuitive Machines for outer space R&D

Musculoskeletal RSS

Musculoskeletal
RSS